ADPH releases infant formula recall details

Published 11:52 am Tuesday, February 22, 2022

Getting your Trinity Audio player ready...

The U.S. Food and Drug Administration (FDA) has issued a Public Health Advisory for powdered formulations of Similac®, Alimentum®, and EleCare®formulas manufactured by Abbott Nutrition in its Sturgis, Michigan, facility. The Alabama WIC Program is notifying participants that they may have been issued affected product.

Abbott Nutrition is voluntarily recalling these products after four consumer complaints related to to Cronobacter sakazakii or SalmonellaNewport in infants who had consumed powder infant formula manufactured in this facility. No distributed product has tested positive for the presence of either of these bacteria; however, routine testing is ongoing. As a proactive measure, the FDA is advising consumers not to use Similac®, Alimentum® and EleCare® powdered formulas if:
· the first two digits of the code are 22 through 37 and
· the code on the container contains K8, SH, pr Z2, and
· the expiration date is 4-1-2022 (APR 2022) or later

Products that do not contain the information listed above are not impacted by the advisory issued by the FDA on February 17. This advisory is for powder formulas only and does not contain other physical formulations such as liquid concentrate or ready-to-feed. This recall does not include any metabolic deficiency nutrition formulas. Persons who have questions or need assistance in locating the product code, are asked to contact Abbott Nutrition Consumer Relations at 1-800-986-8540.

Email newsletter signup

WIC participants should return any of the affected formula to the store or WIC clinic where the products were obtained. WIC participants should be treated the same under store policies with respect to the infant formula recall. At this time, available inventory may be limited. If a participant is unable to complete an exchange, WIC will arrange a reasonable substitute in coordination with the participant’s medical provider. All purchases by either WIC participants or the general public may be returned according to Abbott’s recall website instructions.

Signs and symptoms of illness related to these bacteria and more information are available on FDA’s website and Abbott’s Similac Recall website listed below: